Abstract
Allelic imbalances (AI) of polymorphic markers at the short arm of chromosome 3 (3p) were mapped using DNA samples of renal cell carcinoma (RCC, 80 cases), breast carcinoma (BC, 95 cases), and epithelial ovarian cancer (EOC, 50 cases) at the same dense panel of markers (up to 24 loci). Six regions with the increased AI frequency (versus the average values determined for all the analyzed 3p markers) at RCC, BC or EOC were found in 3p chromosome. Four 3p regions presumably contain tumor-suppressor genes (TSG) involved in the epithelial tumors of various types. Region between D3S2409 and D3S3667 markers in the 3p21.31 region was identified in this study for the first time. The AI peak in D3S2409-D3S3667 region was statistically significant (P < 0.001, according to Fisher) when representative sample set of 95 BC patients was analyzed. The data on increased frequency of polymorphic marker allele amplification suggest that the D3S2409-D3S3667 region contains both putative TSG and protooncogenes.
Similar content being viewed by others
References
Kok, K., Naylor, S.L., and Buys, C.H.C.M., Deletions of the Short Arm of Chromosome 3 in Solid Tumors and the Search for Suppressor Genes, Adv. Cancer Res., 1997, vol. 71, pp. 27–92.
UICC TNM Classification of Malignant Tumors, Sobin, L.Y. and Wittekind, Ch., Eds., New York: Wiley-Liss, 6th ed., 2002.
World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Breast and Female Genital Organs, Tavassoli, F.A. and Devilee, P., Eds., Lyon: IARC, 2003.
World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs, Eble, J.N., Sauter, G.S., Epsten, J.I., and Sisterhenn, I.A., Eds., Lyon: IARC, 2004.
Braga, E., Senchenko, V., Bazov, I., et al., Critical Tumor-Suppressor Gene Regions on Chromosome 3p Regions in Major Human Epithelial Malignancies: Allelotyping and Quantitative Real Time PCR, Int. J. Cancer, 2002, vol. 100, pp. 534–541.
Braga, E.A., Kotova, E.Yu., Pugacheva, E.M., et al., Human Chromosome 3: Microsatellite Search, Distribution Analysis and Creation of New Markers, Mol. Biol. (Moscow), 1997, vol. 31, pp. 988–999.
Weir, B.S., Genetic Data Analysis, Sunderland: Sinauer, 1990.
Thiagalingam, S., Laken, S., Willson, J.K.V., et al., Mechanisms Underlying Losses of Heterozygosity in Human Colorectal Cancers, Proc. Natl. Acad. Sci. USA, 2001, vol. 98, pp. 2698–2702.
Protopopov, A., Kashuba, V., Zabarovska, V.I., et al., An Integrated Physical and Gene Map of the 3.5-Mb Chromosome 3p21.3 (AP20) Region Implicated in Major Human Epithelial Malignancies, Cancer Res., 2003, vol. 63, pp. 404–412.
Kholodnyuk, I., Kost-Alimova, M., Yang, Y., et al., The Microcell Hybrid-Based “Elimination Test” Identifies a 1-Mb Putative Tumor-Suppressor Region at 3p22.2-p22.1 Centromeric to the Homozygous Deletion Region Detected in Lung Cancer, Genes Chromosomes Cancer., 2002, vol. 34, pp. 341–344.
Lerman, M.I. and Minna, J.D., The 630-kb Lung Cancer Homozygous Deletion Region on Human Chromosome 3p21.3: Identification and Evaluation of the Resident Candidate Tumor Suppressor Genes, Cancer Res., 2000, vol. 60, pp. 6116–6133.
Senchenko, V., Liu, J., Loginov, W., et al., Discovery of Frequent Homozygous Deletions in Chromosome 3p21.3 LUCA and AP20 Regions in Renal, Lung and Breast Carcinomas, Oncogene, 2004, vol. 23, pp. 5719–5728.
Dreijerink, K., Braga, E., Kuzmin, I., et al., The Candidate Tumor Suppressor Gene, RASSF1A, from Human Chromosome 3p21.3 Is Involved in Kidney Tumorigenesis, Proc. Natl. Acad. Sci. USA, 2001, vol. 98, pp. 7504–7509.
Li, J., Wang, F., Haraldson, K., et al., Functional Characterization of the Candidate Tumor Suppressor Gene NPRL2/G21 Located in 3p21.3C, Cancer Res., 2004, vol. 64, pp. 6438–6443.
Paterson, H.F., Self, A.J., Garrett, M.D., et al., Microinjection of Recombinant p21rho Induces Rapid Changes in Cell Morphology, J. Cell Biol., 1990, vol. 111, pp. 1001–1007.
Pille, J.Y., Denoyelle, C., Varet, J., et al., Anti-RhoA and Anti-RhoC siRNAs Inhibit the Proliferation and Invasiveness of MDA-MB-231 Breast Cancer Cells in Vitro and in Vivo, Mol. Ther., 2005, vol. 11, pp. 267–274.
Peace, B.E., Hughes, M.J., Degen, S.J.F., and Waltz, S.E., Point Mutations and Overexpression of Ron Induce Transformation, Tumor Formation, and Metastasis, Oncogene, 2001, vol. 20, pp. 6142–6151.
Wang, M.H., Wang, D., and Chen, Y.Q., Oncogenic and Invasive Potentials of Human Macrophage-Stimulating Protein Receptor, the RON Receptor Tyrosine Kinase, Carcinogenes, 2003, vol. 24, pp. 1291–1300.
Faucher, K., Rabinovitch-Chable, H., Barriere, G., et al., Overexpression of Cytosolic Glutathione Peroxidase (GPX1) Delays Endothelial Cell Growth and Increases Resistance to Toxic Challenges, Biochimie, 2003, vol. 85, pp. 611–617.
Sgambato, A., Camerini, A., Faraglia, B., et al., Increased Expression of Dystroglycan Inhibits the Growth and Tumorigenicity of Human Mammary Epithelial Cells, Cancer Biol. Ther., 2004, vol. 3, pp. 967–975.
Varella-Garcia, M., Gemmill, R.M., Rabenhorst, S.H., et al., Chromosomal Duplication Accompanies Allelic Loss in Non-Small Cell Lung Carcinoma, Cancer Res., 1998, vol. 58, pp. 4701–4707.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.I. Loginov, I.V. Bazov, D.S. Khodyrev, I.V. Pronina, T.P. Kazubskaya, V.D. Ermilova, R.F. Garkavtseva, E.R. Zabarovsky, E.A. Braga, 2008, published in Genetika, 2008, Vol. 44, No. 2, pp. 250–256.
Rights and permissions
About this article
Cite this article
Loginov, V.I., Bazov, I.V., Khodyrev, D.S. et al. Human chromosome 3P regions of putative tumor-suppressor genes in renal, breast, and ovarian carcinomas. Russ J Genet 44, 209–214 (2008). https://doi.org/10.1134/S1022795408020142
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1022795408020142